Supplementary Figures: Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breastcancer patients

This work was supported by King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (grant nos. 11-MED2101-46 and 12-MED2226-46), and by a Prostate Cancer Foundation Young Investigator Award (YIA#18YOUN02; SH AlDubayan) and Department of Defense Physician Research Award (W81XWH-21-1-0084, PC200150; SH AlDubayan). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.